It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGROUND: Infective endocarditis (IE) is a life-threatening disease. Despite advancements in diagnostic
methods, the initial clinical presentation of IE remains a valuable asset. Therefore, the impact
of clinical presentation on outcomes and its association with microorganisms and IE localization were
assessed herein.
METHODS: This retrospective study included 183 patients (age 68.9 ± 14.2 years old, 68.9% men)
with definite IE at two tertiary care hospitals in Belgium. Demographic data, medical history, clinical
presentation, blood cultures, imaging data and outcomes were recorded.
RESULTS: In-hospital mortality rate was 22.4%. Sixty (32.8%) patients developed embolism, 42 (23%)
shock, and 103 (56.3%) underwent surgery during hospitalization. Shock at admission predicted
embolism during hospitalization (odds ratio [OR] 2.631, 95% confidence interval [CI] 1.119–6.184,
p = 0.027). A new cardiac murmur at admission predicted cardiac surgery (OR 1.949, 95% CI 1.007–
–3.774, p = 0.048). Methicillin resistant Staphylococcus aureus predicted in-hospital mortality and
shock (p = 0.005, OR 6.945, 95% CI 1.774–27.192 and p = 0.015, OR 4.691, 95% CI 1.348–16.322,
respectively). Mitral valve and aortic valve IE predicted in-hospital death (p = 0.039, OR 2.258, 95%
CI 1.043–4.888) and embolism (p = 0.017, OR 2.328, 95% CI 1.163–4.659), respectively.
CONCLUSIONS: In this retrospective study, shock at admission independently predicted embolism during
hospitalization in IE patients. Moreover, a new cardiac murmur at admission predicted the need
for cardiac surgery. This emphasizes the importance of a comprehensive initial clinical evaluation in
combination with imaging and microbiological data, in order to identify high-risk IE patients early.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Cardiology, Universitair Ziekenhuis Brussel (Centrum voor Hart- en Vaatziekten), Belgium. [email protected]
2 Vrije Universiteit Brussel (Free University of Brussels), Belgium
3 Department of Cardiology, Universitair Ziekenhuis Brussel (Centrum voor Hart- en Vaatziekten), Belgium
4 Department of Internal Medicine and Infectiology, Universitair Ziekenhuis Brussel, Belgium
5 Department of Cardiology, AZ Maria Middelares, Ghent, Belgium
6 Department of Cardiology, Center Hospitalier Universitaire de Limoges, France